With the Bio-IT World Conference opening today in Boston, San Diego-based Illumina (NASDAQ: [[ticker:ILMN) said it has acquired Edico Genome, a five-year-old startup with technology to accelerate the readout of next-generation sequencing data.
Illumina withheld terms of the deal in a statement released this morning. But an Illumina spokeswoman later confirmed that Illumina got Edico for $100 million, close to three times the estimated $32 million that Edico raised in venture funding from Qualcomm Ventures, Dell Technologies Capital, and individual investors.
Edico developed technology that combines a specialized processor and chipset with proprietary software to address a bottleneck in the… Read more »
UNDERWRITERS AND PARTNERS